These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26562367)

  • 1. Apnea of prematurity and caffeine pharmacokinetics: potential impact on hospital discharge.
    Doyle J; Davidson D; Katz S; Varela M; Demeglio D; DeCristofaro J
    J Perinatol; 2016 Feb; 36(2):141-4. PubMed ID: 26562367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum caffeine concentrations in preterm neonates.
    Leon AE; Michienzi K; Ma CX; Hutchison AA
    Am J Perinatol; 2007 Jan; 24(1):39-47. PubMed ID: 17195151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine pharmacokinetics in preterm infants older than 2 weeks.
    Pearlman SA; Duran C; Wood MA; Maisels MJ; Berlin CM
    Dev Pharmacol Ther; 1989; 12(2):65-9. PubMed ID: 2714159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding.
    Le Guennec JC; Billon B; Paré C
    Pediatrics; 1985 Nov; 76(5):834-40. PubMed ID: 4058995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between plasma and urinary caffeine levels in preterm infants.
    Cattarossi L; Violino M; Macagno F; Logreco P; Savoia M
    J Perinat Med; 2006; 34(4):344-6. PubMed ID: 16856829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stopping caffeine in premature neonates: how long does it take for the level of caffeine to fall below the therapeutic range?
    Chung J; Tran Lopez K; Amendolia B; Bhat V; Nakhla T; Slater-Myer L; Saslow J; Aghai ZH
    J Matern Fetal Neonatal Med; 2022 Feb; 35(3):551-555. PubMed ID: 32079435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity.
    García-Robles A; Solaz-García Á; Verdú-Andrés J; Andrés JLP; Cañada-Martínez AJ; Pericás CC; Ponce-Rodriguez HD; Vento M; González PS
    Eur J Pediatr; 2022 Dec; 181(12):4175-4182. PubMed ID: 36169712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.
    Lee TC; Charles B; Steer P; Flenady V; Shearman A
    Clin Pharmacol Ther; 1997 Jun; 61(6):628-40. PubMed ID: 9209245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-based differences in apnoea of prematurity: A retrospective cohort study.
    Bairam A; Laflamme N; Drolet C; Piedboeuf B; Shah PS; Kinkead R;
    Exp Physiol; 2018 Oct; 103(10):1403-1411. PubMed ID: 29974527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
    Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM
    BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
    Zhao Y; Tian X; Liu G
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental aspects of percutaneous caffeine absorption in premature infants.
    Amato M; Hüppi P; Isenschmid M; Schneider H
    Am J Perinatol; 1992; 9(5-6):431-4. PubMed ID: 1418150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise?
    Natarajan G; Botica ML; Thomas R; Aranda JV
    Pediatrics; 2007 May; 119(5):936-40. PubMed ID: 17473094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
    Ducrocq S; Biran-Mucignat V; Boelle PY; Lebas F; Baudon JJ; Gold F
    Arch Pediatr; 2006 Oct; 13(10):1299-304. PubMed ID: 16919922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of caffeine on preterm infants' cerebral cortical activity: an observational study.
    Hassanein SM; Gad GI; Ismail RI; Diab M
    J Matern Fetal Neonatal Med; 2015; 28(17):2090-5. PubMed ID: 25330842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Margin of safety for discharge after apnea in preterm infants.
    Darnall RA; Kattwinkel J; Nattie C; Robinson M
    Pediatrics; 1997 Nov; 100(5):795-801. PubMed ID: 9346978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.